Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Comment by Runnerhunteron Aug 19, 2019 3:11pm
50 Views
Post# 30043980

RE:RE:RE:RE:RE:RE:Imagine closing red LAUGHING OUT LOUD

RE:RE:RE:RE:RE:RE:Imagine closing red LAUGHING OUT LOUDYou seems to confuse sales with revenues, which is a funny mistake isol pumpers used to all do.

isol sales are shady just as MJNA ones, not only does isol generat 20m but that revenue doesn’t even clear the cost of good sales and all their fees making them go negative financial after financial.

also, their revenue cant be comming from sells because they CANT sell their products. They dont have any distributions agreements, or the one they c’aimed to have got terminated after people started doing deep research on who and what were cn pharma... strange isn’t it?

also if your to bring the fact that isol made a deal to sell product on 10 000 store across the US why does the revenues are more or less the same they were prior to that « wonderfull deal »

Also generating 20m in revenue didn’t stop isol to drop 1000% away from where they were one year ago. And thats while showing revenue financial after financials...

stop sticking to revenue and only revenue because it doesn’t matter AT ALL, MJNA GENERAT about 9m a quarter and that didn’t stop them to trade between 0,10 to 0,20 for over 4 years.

you being only stuck on the revenue really shows how much of an amateur you are. Financial statement, especially the audited one, is the most usefull tool an investor could use. And if you only look at the revenue you will be caught into pump and dump like those


Bullboard Posts